← Back to headlines
Johnson & Johnson Benefits from Strong Growth Pipeline and Key Therapeutic Areas
Johnson & Johnson (JNJ) is experiencing positive performance, driven by its robust growth pipeline and strong presence across several key therapeutic areas.
31 Mar, 16:05 — 31 Mar, 16:05
Sources
Showing 1 of 1 sources
